A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment

Inclusion Criteria: For Test Group 1 and 2 - subjects with renal impairment 1. Age 19\~65 2. BMI 18.0\~30.0 kg/m\^2 (Body mass index) 3. 30 ≤ eGFR \< 60 mL/min/1.73m\^2 (estimated glomerular filtration rate) 4. voluntarily given written informed consent For Control Group - healthy subjects 1. Age ≥ 19 2. BMI 18.0\~30.0 kg/m\^2 3. eGFR ≥ 90 mL/min/1.73m\^2 4. voluntarily given written informed consent Exclusion Criteria: For Test Group 1 and 2 - subjects with renal impairment 1. Medical history * Subjects with lactic acidosis or marked hepatotoxicity * Not controlled diabetes, hypertension, dyslipidemia * requiring dialysis 2. Clinical examination * AST, ALT \> 2, Bilirubin total, γ-GTP \> 1.5, CK \> 2 times the upper limit of normal ranges (Aspartate transaminase, Alanine transaminase, gamma-Glutamyl transpeptidase, Creatine phosphokinase) * Positive serologic results 3. Drug hypersensitivity and drug abuse For Control Group - healthy subjects 1. Medical history * History of chronic liver disease, hepatic encephalopathy, ascites, or upper gastrointestinal bleeding * Subjects with lactic acidosis or marked hepatotoxicity 2. Clinical examination * AST, ALT \> 2, Bilirubin total, γ-GTP \> 1.5, CK \> 2 times the upper limit of normal ranges * Positive serologic results 3. Drug hypersensitivity and drug abuse